Inventory Turnover measures how fast the company turns over its inventory within a year.
China Resources Pharmaceutical Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.70.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Resources Pharmaceutical Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.31.
China Resources Pharmaceutical Group (STU:640) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
China Resources Pharmaceutical Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Resources Pharmaceutical Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
China Resources Pharmaceutical Group Days Inventory Related Terms
China Resources Pharmaceutical Group Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Pharmaceutical Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where China Resources Pharmaceutical Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Pharmaceutical Group (STU:640) has a Days Inventory of 67.64 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Resources Pharmaceutical Group and its competitors. This is 32% above median its historical median of 51.11. Over the past decade, China Resources Pharmaceutical Group's Days Inventory has ranged from 46.92 to 65.52. According to the industry distribution chart, China Resources Pharmaceutical Group ranks #82 out of 919 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is China Resources Pharmaceutical Group's Days Inventory too high?
China Resources Pharmaceutical Group's current Days Inventory of 67.64 is 32% above median its 10-year median of 51.11. Over the past 10 years, this metric has ranged from a low of 46.92 to a high of 65.52. The Drug Manufacturers industry median Days Inventory is 164.48. China Resources Pharmaceutical Group's value of 67.64 is 58.9% below this industry median. Based on the distribution chart, China Resources Pharmaceutical Group ranks #82 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Pharmaceutical Group has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Resources Pharmaceutical Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Resources Pharmaceutical Group ranks #82 out of 919 companies for Days Inventory. This places China Resources Pharmaceutical Group in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. China Resources Pharmaceutical Group's value of 67.64 is 58.9% below this benchmark. Historically, China Resources Pharmaceutical Group's own Days Inventory has ranged from 46.92 to 65.52 over the past decade. While the company's 10-year median is 51.11 vs. the industry median of 164.48, China Resources Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Pharmaceutical Group's current Days Inventory of 67.64 is 58.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Resources Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Pharmaceutical Group's current Days Inventory is 67.64, which is 32% above median its own 10-year median of 51.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group (STU:640) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.64, compared to a current price of €0.49 — trading 23.4% below its estimated fair value. The current Days Inventory is 67.64, which is 32% above median its 10-year median of 51.11 and 58.9% below the Drug Manufacturers industry median of 164.48. China Resources Pharmaceutical Group's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For China Resources Pharmaceutical Group (STU:640), the current Days Inventory is 67.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Pharmaceutical Group (STU:640) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued.
The current stock price of €0.49 is trading 23.4% below its estimated GF Value™ of €0.64.
GuruFocus considers China Resources Pharmaceutical Group to be Modestly Undervalued.
Key valuation signals for STU:640:
Days Inventory: 67.64 (32% above median its 10-year median of 51.11)
GF Value™: €0.64 vs. price of €0.49 (23.4% below fair value)
Industry Position: 58.9% below the Drug Manufacturers median (#82 of 919)
No single metric tells the full story. See the STU:640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Pharmaceutical Group Business Description
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
63GF Score
Get the complete analysis for STU:640
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:640 has been successfully added to your 
